Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX
Clinical trial NCT06210360 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06210360
- Sponsor
- Changhai Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2025-04-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.